146 related articles for article (PubMed ID: 37584829)
1. PIAS1 impedes vascular endothelial injury and atherosclerotic plaque formation in diabetes by blocking the RUNX3/TSP-1 axis.
Jin Q; Zhao T; Lin L; Yao X; Teng Y; Zhang D; Jin Y; Yang M
Hum Cell; 2023 Nov; 36(6):1915-1927. PubMed ID: 37584829
[TBL] [Abstract][Full Text] [Related]
2. RUNX family members are covalently modified and regulated by PIAS1-mediated sumoylation.
Kim JH; Jang JW; Lee YS; Lee JW; Chi XZ; Li YH; Kim MK; Kim DM; Choi BS; Kim J; Kim HM; van Wijnen A; Park I; Bae SC
Oncogenesis; 2014 Apr; 3(4):e101. PubMed ID: 24777122
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
Heo KS; Chang E; Takei Y; Le NT; Woo CH; Sullivan MA; Morrell C; Fujiwara K; Abe J
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):321-9. PubMed ID: 23202365
[TBL] [Abstract][Full Text] [Related]
4. PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation.
Xie B; Liu X; Yang J; Cheng J; Gu J; Xue S
BMC Cell Biol; 2018 Nov; 19(1):24. PubMed ID: 30419807
[TBL] [Abstract][Full Text] [Related]
5. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells.
Woo CH; Shishido T; McClain C; Lim JH; Li JD; Yang J; Yan C; Abe J
Circ Res; 2008 Mar; 102(5):538-45. PubMed ID: 18218985
[TBL] [Abstract][Full Text] [Related]
6. PIAS1 Alleviates Hepatic Ischemia-Reperfusion Injury in Mice through a Mechanism Involving NFATc1 SUMOylation.
Luo J; Li J; Li T; Zhang Z; Chen G; Li Q; Qi H; Si Z
Dis Markers; 2022; 2022():4988539. PubMed ID: 36092961
[TBL] [Abstract][Full Text] [Related]
7. Tumor Suppressor p14ARF Enhances IFN-γ-Activated Immune Response by Inhibiting PIAS1 via SUMOylation.
Alagu J; Itahana Y; Sim F; Chao SH; Bi X; Itahana K
J Immunol; 2018 Jul; 201(2):451-464. PubMed ID: 29848755
[TBL] [Abstract][Full Text] [Related]
8. Protein inhibitor of activated STAT1 Ser
Liu SY; Ma YL; Hsu WL; Chiou HY; Lee EHY
Br J Pharmacol; 2019 Jun; 176(11):1793-1810. PubMed ID: 30849179
[TBL] [Abstract][Full Text] [Related]
9. Sumoylation of PPARγ contributes to vascular endothelium insulin resistance through stabilizing the PPARγ-NcoR complex.
Lan D; Shen X; Yuan W; Zhou Y; Huang Q
J Cell Physiol; 2019 Nov; 234(11):19663-19674. PubMed ID: 30982983
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of E3 ubiquitin ligase Cbl attenuates endothelial dysfunction in diabetes mellitus by inhibiting the JAK2/STAT4 signaling and Runx3-mediated H3K4me3.
Jin Q; Lin L; Zhao T; Yao X; Teng Y; Zhang D; Jin Y; Yang M
J Transl Med; 2021 Nov; 19(1):469. PubMed ID: 34798872
[TBL] [Abstract][Full Text] [Related]
11. The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.
Li S; Yang C; Hong Y; Bi H; Zhao F; Liu Y; Ao X; Pang P; Xing X; Chang AK; Xiao L; Zhang Y; Wu H
Biol Cell; 2012 May; 104(5):287-96. PubMed ID: 22283414
[TBL] [Abstract][Full Text] [Related]
12. Small heterodimer partner (SHP) aggravates ER stress in Parkinson's disease-linked LRRK2 mutant astrocyte by regulating XBP1 SUMOylation.
Lee JH; Han JH; Joe EH; Jou I
J Biomed Sci; 2021 Jul; 28(1):51. PubMed ID: 34229656
[TBL] [Abstract][Full Text] [Related]
13. Effects of MEK5/ERK5 association on small ubiquitin-related modification of ERK5: implications for diabetic ventricular dysfunction after myocardial infarction.
Shishido T; Woo CH; Ding B; McClain C; Molina CA; Yan C; Yang J; Abe J
Circ Res; 2008 Jun; 102(11):1416-25. PubMed ID: 18467627
[TBL] [Abstract][Full Text] [Related]
14. Linking nuclear matrix-localized PIAS1 to chromatin SUMOylation via direct binding of histones H3 and H2A.Z.
Chen Z; Zhang Y; Guan Q; Zhang H; Luo J; Li J; Wei W; Xu X; Liao L; Wong J; Li J
J Biol Chem; 2021 Oct; 297(4):101200. PubMed ID: 34537242
[TBL] [Abstract][Full Text] [Related]
15. A role for protein inhibitor of activated STAT1 (PIAS1) in lipogenic regulation through SUMOylation-independent suppression of liver X receptors.
Zhang Y; Gan Z; Huang P; Zhou L; Mao T; Shao M; Jiang X; Chen Y; Ying H; Cao M; Li J; Li J; Zhang WJ; Yang L; Liu Y
J Biol Chem; 2012 Nov; 287(45):37973-85. PubMed ID: 22969086
[TBL] [Abstract][Full Text] [Related]
16. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
[TBL] [Abstract][Full Text] [Related]
17. PIAS1 mediates TGFbeta-induced SM alpha-actin gene expression through inhibition of KLF4 function-expression by protein sumoylation.
Kawai-Kowase K; Ohshima T; Matsui H; Tanaka T; Shimizu T; Iso T; Arai M; Owens GK; Kurabayashi M
Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):99-106. PubMed ID: 18927467
[TBL] [Abstract][Full Text] [Related]
18. The E3 Ligase PIAS1 Regulates p53 Sumoylation to Control Stress-Induced Apoptosis of Lens Epithelial Cells Through the Proapoptotic Regulator Bax.
Nie Q; Chen H; Zou M; Wang L; Hou M; Xiang JW; Luo Z; Gong XD; Fu JL; Wang Y; Zheng SY; Xiao Y; Gan YW; Gao Q; Bai YY; Wang JM; Zhang L; Tang XC; Hu X; Gong L; Liu Y; Li DW
Front Cell Dev Biol; 2021; 9():660494. PubMed ID: 34195189
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3.
Meng S; Cao J; Zhang X; Fan Y; Fang L; Wang C; Lv Z; Fu D; Li Y
PLoS One; 2013; 8(7):e68611. PubMed ID: 23874686
[TBL] [Abstract][Full Text] [Related]
20. PIAS1-mediated SUMOylation of influenza A virus PB2 restricts viral replication and virulence.
Wang G; Zhao Y; Zhou Y; Jiang L; Liang L; Kong F; Yan Y; Wang X; Wang Y; Wen X; Zeng X; Tian G; Deng G; Shi J; Liu L; Chen H; Li C
PLoS Pathog; 2022 Apr; 18(4):e1010446. PubMed ID: 35377920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]